Titash Sen

Titash Sen, PhD, currently serves as Associate Principal Team Lead at Lonza since March 2024. Prior to this role, Titash held a position as Senior Scientist at Evox Therapeutics Ltd from May 2022 to March 2024, focusing on platform development projects aimed at enhancing gene editing and mRNA therapeutic delivery through exosomes. Experience includes significant contributions at AstraZeneca as a Postdoctoral Scientist from November 2020 to April 2022, where Titash led a cross-functional platform development project in collaboration with the University of Sheffield. Earlier, Titash worked as a Post-doctoral Researcher at Institut Curie from September 2018 to August 2020, investigating drug resistance mechanisms in melanoma. Initial research experience was gained at the Saha Institute of Nuclear Physics as a Master Thesis Student. Titash holds a PhD in RNA Biology from the Indian Institute of Science, complemented by a Master of Science in Biotechnology from St. Xavier's College, Kolkata.